Stay updated on Nivolumab-Ixazomib Combo in MM: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab-Ixazomib Combo in MM: Clinical Trial page.

Latest updates to the Nivolumab-Ixazomib Combo in MM: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new version entry, v3.6.5, has been added to the revision history, replacing the previous v3.6.4, indicating a deployment or QA update to the page rather than a modification of the study details.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the study record history and the previous Revision: v3.6.3 entry was removed, signaling a minor update to the page’s version-tracking UI.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study history page shows the revision label updated from v3.6.2 to v3.6.3, replacing the previous version. This reflects a page update or quality-control refresh to the record rather than a substantive change to trial data.SummaryDifference0.1%

- Check54 days agoChange DetectedA newer revision entry (v3.6.2) is added to the study record history. The older revision (v3.6.0) is removed from the latest history, reflecting an update to the page's versioning.SummaryDifference0.1%

- Check68 days agoChange DetectedRecruitment status updated to no longer looking for participants, indicating the study is closed to enrollment. The record version advanced to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.6%

- Check75 days agoChange DetectedThe history now records a new revision, v3.5.5, and removes the previous revision, v3.5.4. This reflects version control of the ClinicalTrials.gov entry rather than substantive changes to the study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab-Ixazomib Combo in MM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ixazomib Combo in MM: Clinical Trial page.